Press release dated August 05, 2026, titled "Biocon Q1FY27 Total Income at Rs 4,391 Cr, Up 9%; EBITDA at Rs…
As filed · Biocon Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Biocon Q1FY27 Total Income at Rs 4,391 Cr, Up 9%; EBITDA at Rs 902 Cr; Net Profit at Rs 141 Cr; Biopha
What happened
FactBiocon Limited announced its un-audited consolidated financial results for the quarter ended June 30, 2026, reporting total income of Rs 4,391 crore, an increase of 9%. The company's EBITDA was Rs 902 crore, and net profit stood at Rs 141 crore, with biopharma revenue rising by 17%. The press release is available on the company's website.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Market Share
WithdrawnThis is a $9 billion opportunity.
It is really up to us to take this market share in a very responsible manner so that we can provide options to patients for a very, very long time.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Looking ahead, we remain focused on the strategic expansion of our differentiated GLP-1 portfolio into new mar (management committed by FY26)
- the focus has always been to see that we have a new product launch either in the US or in Europe every year fr (management committed by FY27)
Evidence
- Biocon Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Biocon Q1FY27 Total Income at Rs 4,391 Cr, Up 9%; EBITDA at Rs 902 Cr; Net Profit at Rs 141 Cr; Biopharma Revenue Up 17%".(opens the original filing in a new tab)
- Earlier statement · Q4 FY25
- Latest statement · Q2 FY26
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%